Thesis (Master's)--University of Washington, 2018Objective: To describe time trends in Viral Load (VL) tests and results and time trends in use of second-line antiretroviral regimens for treatment of HIV/AIDS, and eventually to explore the association between VL test and second line regimen switching. Study Design: We conducted a retrospective cohort study with over 80,000 patients drawn from 88 of 160 Haiti's national ART sites. Longitudinal data from the iSanté electronic data system was used to analyze time trends in the routine use of VL testing and switching to second-line ART treatments. We calculated the odds ratio of second-line regimen switching with 95% confidence intervals (CI) comparing patients never tested, patients tested wit...
BACKGROUND: Although considered an essential tool for monitoring the effect of combination antiretro...
BACKGROUND: In high-income countries, viral load is routinely measured to detect failure of antiretr...
International audienceBACKGROUND: The decision about whether to switch to third-line antiretroviral ...
Thesis (Master's)--University of Washington, 2018Objective: To describe time trends in Viral Load (V...
Background: High attrition during the period from HIV testing to antiretroviral therapy (ART) initia...
BACKGROUND:The viral load (VL) in patients receiving antiretroviral therapy (ART) is the best predic...
Thesis (Master's)--University of Washington, 2018Background: Previous research suggests that communi...
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced ...
International audienceBACKGROUND: In high-income countries, viral load is routinely measured to dete...
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced ...
IntroductionViral load (VL) assessment is the preferred method for diagnosing and confirming virolog...
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced ...
INTRODUCTION: Aiming to reach UNAIDS 90-90-90 targets, nearly all sub-Saharan African countries have...
<div><p>Background</p><p>The viral load (VL) in patients receiving antiretroviral therapy (ART) is t...
Introduction: Standard-of-care antiretroviral treatment (ART) monitoring in low and middle-income co...
BACKGROUND: Although considered an essential tool for monitoring the effect of combination antiretro...
BACKGROUND: In high-income countries, viral load is routinely measured to detect failure of antiretr...
International audienceBACKGROUND: The decision about whether to switch to third-line antiretroviral ...
Thesis (Master's)--University of Washington, 2018Objective: To describe time trends in Viral Load (V...
Background: High attrition during the period from HIV testing to antiretroviral therapy (ART) initia...
BACKGROUND:The viral load (VL) in patients receiving antiretroviral therapy (ART) is the best predic...
Thesis (Master's)--University of Washington, 2018Background: Previous research suggests that communi...
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced ...
International audienceBACKGROUND: In high-income countries, viral load is routinely measured to dete...
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced ...
IntroductionViral load (VL) assessment is the preferred method for diagnosing and confirming virolog...
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced ...
INTRODUCTION: Aiming to reach UNAIDS 90-90-90 targets, nearly all sub-Saharan African countries have...
<div><p>Background</p><p>The viral load (VL) in patients receiving antiretroviral therapy (ART) is t...
Introduction: Standard-of-care antiretroviral treatment (ART) monitoring in low and middle-income co...
BACKGROUND: Although considered an essential tool for monitoring the effect of combination antiretro...
BACKGROUND: In high-income countries, viral load is routinely measured to detect failure of antiretr...
International audienceBACKGROUND: The decision about whether to switch to third-line antiretroviral ...